Horn L - Search Results

1

Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer: ECOG-ACRIN 5508.

Ramalingam SS, Dahlberg SE, Belani CP, Saltzman JN, Pennell NA, Nambudiri GS, McCann JC, Winegarden JD, Kassem MA, Mohamed MK, Rothman JM, Lyss AP, Horn L, Stinchcombe TE, Schiller JH. Ramalingam SS, et al. Among authors: horn l. J Clin Oncol. 2019 Sep 10;37(26):2360-2367. doi: 10.1200/JCO.19.01006. Epub 2019 Jul 30. J Clin Oncol. 2019. PMID: 31361535 Free PMC article. Clinical Trial.

2

Evarts A. Graham and the first pneumonectomy for lung cancer.

Horn L, Johnson DH. Horn L, et al. J Clin Oncol. 2008 Jul 1;26(19):3268-75. doi: 10.1200/JCO.2008.16.8260. J Clin Oncol. 2008. PMID: 18591561 No abstract available.

3

A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): a trial of the Eastern Cooperative Oncology Group.

Horn L, Bernardo P, Sandler A, Wagner H, Levitan N, Levitt ML, Johnson DH. Horn L, et al. J Thorac Oncol. 2009 Apr;4(4):527-33. doi: 10.1097/JTO.0b013e31819c7daf. J Thorac Oncol. 2009. PMID: 19240650 Free PMC article. Clinical Trial.

4

Angiogenesis in the treatment of non-small cell lung cancer.

Horn L, Sandler AB. Horn L, et al. Proc Am Thorac Soc. 2009 Apr 15;6(2):206-17. doi: 10.1513/pats.200807-066LC. Proc Am Thorac Soc. 2009. PMID: 19349490 Free PMC article. Review.

5

Emerging data with antiangiogenic therapies in early and advanced non-small-cell lung cancer.

Horn L, Sandler AB. Horn L, et al. Clin Lung Cancer. 2009 Mar;10 Suppl 1(Suppl 1):S7-16. doi: 10.3816/CLC.2009.s.002. Clin Lung Cancer. 2009. PMID: 19362948 Free PMC article. Review.

6

EML4-ALK: honing in on a new target in non-small-cell lung cancer.

Horn L, Pao W. Horn L, et al. J Clin Oncol. 2009 Sep 10;27(26):4232-5. doi: 10.1200/JCO.2009.23.6661. Epub 2009 Aug 10. J Clin Oncol. 2009. PMID: 19667260 Free PMC article. No abstract available.

7

Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer.

Horn L, Sandler A. Horn L, et al. Clin Cancer Res. 2009 Aug 15;15(16):5040-8. doi: 10.1158/1078-0432.CCR-09-0520. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671872 Free PMC article. Review.

8

Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501.

Horn L, Dahlberg SE, Sandler AB, Dowlati A, Moore DF, Murren JR, Schiller JH. Horn L, et al. J Clin Oncol. 2009 Dec 10;27(35):6006-11. doi: 10.1200/JCO.2009.23.7545. Epub 2009 Oct 13. J Clin Oncol. 2009. PMID: 19826110 Free PMC article. Clinical Trial.

9

Update on new drugs in small cell lung cancer.

Horn L, Castellanos EL, Johnson DH. Horn L, et al. Expert Opin Investig Drugs. 2011 Apr;20(4):441-5. doi: 10.1517/13543784.2011.553185. Expert Opin Investig Drugs. 2011. PMID: 21395484 Review.

10

Molecular predictors of response to chemotherapy in non-small cell lung cancer.

Andrews J, Yeh P, Pao W, Horn L. Andrews J, et al. Among authors: horn l. Cancer J. 2011 Mar-Apr;17(2):104-13. doi: 10.1097/PPO.0b013e318213f3cf. Cancer J. 2011. PMID: 21427554 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,327 results

Search Page